Bioproduction Group(Bio-G)

In this whitepaper we examine the key metrics involved in capacity decisions for biopharmaceutical operations. We demonstrate how to model demand as well as existing and new supply capacity in the 1-10 year planning horizon. Using simple models of risk and variability, we demonstrate how integrated ‘supply-demand’ models can be used to accurately predict and prepare manufacturing capacity for the pipeline.

In this whitepaper we examine the major issues with biomanufacturing supply chains and how to balance inventory and risk optimally in the manufacturing network, in real-time. We examine critical risks facing the biomanufacturing industry and explain how to address them.